As shown in Figure 4A (left panel), compared with the lal+/+ MSC-CM treatment, both FVB/N and C57BL/6 lal−/− MSC-CM showed a lower stimulatory effect on proliferation of B16 melanoma cells after 3 days. This evidence concerns the gene LIPA and melanoma.